ID   CD36E
AC   CVCL_ZD82
DR   ABM; T0136
DR   Kerafast; ENH035-FP
DR   Wikidata; Q98125613
RX   PubMed=20696208;
WW   https://www.ott.nih.gov/technology/e-151-2010-0
CC   Group: Malaria research cell line.
CC   Characteristics: Potentially useful for culturing Plasmodium vivax and other species of malaria; useful for hematological disease applications involving red blood cells or red blood cell precursors (Kerafast=ENH035-FP).
CC   Doubling time: 3-4 days (PubMed=20696208).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; S.alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Caution: ABM wrongly indicates that this cell line originates from mouse (ABM=T0136).
CC   Discontinued: ABM; T0136; probable.
CC   Discontinued: Kerafast; ENH035-FP; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroid progenitor cell; CL=CL_0000038.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 10-09-24; Version: 9
//
RX   PubMed=20696208; DOI=10.1016/j.exphem.2010.07.012; PMCID=PMC6341492;
RA   Wong S., Keyvanfar K., Wan Z.-H., Kajigaya S., Young N.S., Zhi N.;
RT   "Establishment of an erythroid cell line from primary CD36+ erythroid
RT   progenitor cells.";
RL   Exp. Hematol. 38:994-1005.e10052(2010).
//